Cartesian Growth Corporation Warrant (GLBLW) Peer Comparison
$0.51
As on 30-Dec-2022 15:59EDT
Market cap
$419 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
1.7
P/B Ratio
0
Div. Yield
0 %
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
419 | 756 | 434 | 433 | 418 |
Revenue ($ Mln) |
-- | -- | -- | -- | -- |
Net Profit ($ Mln) |
18.36 | 15.28 | 4,997,575.85 | 39.04 | 14.98 |
Net Margin (%) |
92.81 | 61.54 | 23,870,982.27 | 346.40 | 74.54 |
RoE (%) |
5.66 | -- | -- | -- | -- |
Price to Earnings |
1.72 | 48.00 | 22.89 | 52.84 | 27.30 |
Price-To-Book |
-- | 1.31 | 1.27 | 1.30 | 1.32 |
Income Statement ($ Mln)
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Cost of Revenue
|
1.01 | -- | 0.20 | -- | -- |
|
Gross Profit
|
-1.01 | -- | -0.20 | -- | -- |
|
Operating Expenses
|
1.01 | 1.05 | 0.94 | 1.27 | -0.11 |
|
Operating Profit (EBIT)
|
-1.01 | -1.05 | -1.14 | -1.27 | -0.12 |
|
Other Income
|
-0.02 | -- | 6.79 | 4.27 | -- |
|
Profit before Tax
|
-1.04 | 9.39 | 5.65 | 3.00 | -0.12 |
|
Provision for Tax
|
-- | -- | -- | -- | -- |
|
Profit after Tax (Net Income)
|
-1.04 | 9.39 | 5.65 | 3.00 | -0.12 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-1.04 | 9.39 | 5.65 | -22.97 | 10.62 |
Liabilities ($ Mln)
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
0.00 | -0.04 | 0.00 | -20.84 | 320.82 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
0.00 | 0.04 | 0.00 | 21.07 | 11.59 |
|
Current Liabilities
|
0.00 | 0.00 | 0.00 | 0.36 | 0.18 |
|
Total Liabilities
|
0.00 | 0.60 | 0.00 | 345.59 | 332.59 |
Assets ($ Mln)
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.00 | 0.60 | 0.00 | 345.02 | 331.19 |
|
Current Assets
|
0.00 | 0.00 | 0.00 | 0.56 | 1.40 |
|
Total Assets
|
0.00 | 0.00 | 0.00 | 0.59 | 332.59 |
|
Total Debt*
|
-- | 0.03 | 0.02 | -- | -- |
|
Net Current Assets
|
0.44 | 0.48 | 0.70 | 0.20 | 0.74 |
Cashflow ($ Mln)
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.91 | -0.85 | -1.30 | -1.34 | -0.91 |
|
Cash Flow from Investing Activities
|
-345.00 | -600.00 | -345.00 | -345.00 | 0.13 |
|
Cash from Financing Activities
|
346.46 | 601.56 | 347.03 | 346.54 | 0.60 |
|
Net Cash Inflow / Outflow
|
0.55 | -- | 0.73 | 0.20 | -- |
Ratios
Profitability Ratios
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-12,168.77 | 152,961.95 | 30,139.91 | -- | -0.04 |
|
ROE (%)
|
-12,168.77 | -140,579.43 | 58,411.47 | -- | -0.04 |
|
ROA (%)
|
-1,580.35 | 2,083.49 | 29,667.42 | -- | -0.03 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
4,515.00 | -- | 83.15 | 70.33 | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- | -- | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-12,923.65 | -- | 100,259.10 | -- | 0.00 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-46.23 | 15.52 | 15.53 | 140.08 | -673.18 |
|
Price / Book Value
|
-1,367,678.57 | -3,930.13 | -3,988,636.36 | -20.17 | 0.24 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-46.23 | 15.52 | 15.53 | 140.02 | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.08 | 0.94 | -- | -- |
|
Short term debt to equity ratio
|
-659,817.37 | 1.08 | 0.94 | -- | -- |
|
Current Ratio
|
0.00 | 2.06 | 0.00 | 1.56 | 7.93 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | -- | -- | -- | -- |
Operating Efficiency Ratios
| Cartesian Growth Corporation Warrant (GLBLW) | Hudson Executive Investment Corp III (HIII) | Colicity Inc. Class A (COLI) | RXRcquisition Corp. Class A (RXRA) | Healthcare Services Acquisition Corp (HCAR) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- | -- | -- |
|
Asset Turnover
|
0.00 | 0.00 | 0.00 | -- | 0.00 |
|
Receivable days
|
-- | -- | -- | -- | -- |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
0.00 | -- | 211.59 | -- | -- |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |